HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Paul Tapang Selected Research
Paul Tapang Research Topics
Disease
13
Neoplasms (Cancer)
12/2012 - 01/2002
3
Fibrosarcoma
07/2011 - 04/2006
2
Carcinoma (Carcinomatosis)
07/2011 - 11/2003
2
Edema (Dropsy)
04/2007 - 04/2006
1
Multiple Myeloma
01/2016
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2012
1
Lymphoma (Lymphomas)
12/2012
1
Hematologic Neoplasms (Hematological Malignancy)
12/2012
1
Leukemia
12/2012
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2012
1
Polyploidy
12/2012
1
Colorectal Neoplasms (Colorectal Cancer)
10/2012
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012
1
Hypertension (High Blood Pressure)
06/2009
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2007
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2006
1
Glioma (Gliomas)
04/2006
1
Corneal Neovascularization
04/2006
1
Carcinogenesis
04/2005
1
Sarcoma (Soft Tissue Sarcoma)
11/2003
1
Neuroblastoma
11/2003
Drug/Important Bio-Agent (IBA)
5
linifanib
IBA
06/2012 - 04/2006
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
07/2011 - 04/2007
2
Proteins (Proteins, Gene)
FDA Link
01/2016 - 07/2011
2
Urea (Carbamide)
FDA Link
Generic
05/2012 - 06/2009
2
Phosphotransferases (Kinase)
IBA
04/2007 - 04/2006
1
venetoclax
IBA
01/2016
1
Bortezomib (Velcade)
FDA Link
01/2016
1
navitoclax
IBA
01/2016
1
Pharmaceutical Preparations
IBA
01/2016
1
src-Family Kinases
IBA
12/2012
1
Histones (Histone)
IBA
12/2012
1
Imatinib Mesylate (Gleevec)
FDA Link
12/2012
1
ilorasertib
IBA
12/2012
1
Irinotecan (Camptosar)
FDA Link
Generic
10/2012
1
Glucose (Dextrose)
FDA Link
Generic
10/2012
1
Thymidine
IBA
10/2012
1
Biomarkers (Surrogate Marker)
IBA
06/2012
1
diphenyl (biphenyl)
IBA
05/2012
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
07/2011
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
07/2011
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
06/2009
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
06/2009
1
Angiotensin Receptor Antagonists
IBA
06/2009
1
Calcium Channel Blockers (Blockers, Calcium Channel)
IBA
06/2009
1
Enalapril
FDA Link
Generic
06/2009
1
Antihypertensive Agents (Antihypertensives)
IBA
06/2009
1
Transferases
IBA
04/2007
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2007
1
Estradiol (Delestrogen)
FDA Link
Generic
04/2007
1
Blood Proteins (Serum Proteins)
IBA
04/2006
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2006
1
Small Interfering RNA (siRNA)
IBA
04/2005
1
Polo-Like Kinase 1
IBA
04/2005
1
Agar
IBA
04/2005
1
Aminopeptidases
IBA
11/2003
1
Antineoplastic Agents (Antineoplastics)
IBA
11/2003
1
O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)
IBA
11/2003
1
A357300
IBA
11/2003
1
Methionine (L-Methionine)
FDA Link
11/2003
1
Enzymes
IBA
11/2003
1
Amides
IBA
10/2003
1
N- (1- (2,2- dimethyl- 1,3- dioxol- 4- yl)- 2- ((4,4- (trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)- N- hydroxyformamide
IBA
01/2002
1
Matrix Metalloproteinase Inhibitors
IBA
01/2002
Therapy/Procedure
2
Therapeutics
10/2012 - 11/2003
1
Intraperitoneal Injections
10/2012
1
Aftercare (After-Treatment)
07/2011